Canaan Partners Leads Vedana Therapeutics Series A
Canaan Partners led a Series A for Vedana Therapeutics, extending the firm’s healthcare franchise as it deploys its $850M Fund XIII.
Explore our latest articles on biotech — covering venture capital deals, fund activity, startup fundraising strategy, and investor research relevant to this topic.
Whether you're a founder building an investor target list, an analyst tracking deal flow, or an operator researching market trends, the articles below provide practical, up-to-date venture capital intelligence.
Browse all biotech articles below, or use our VC directory to research active investors by stage and sector.
Canaan Partners led a Series A for Vedana Therapeutics, extending the firm’s healthcare franchise as it deploys its $850M Fund XIII.
NYC digital health raised $2.4B in H1 2025 (+10% YoY). Life sciences took 27% of NYC venture funding. Here's where the money went and who's writing checks.
BDC Capital's life sciences venture fund bolsters Canadian therapeutics and medtech — an underrated pipeline for U.S. and EU follow-on rounds.
Boston startups raised $16.7B in 2025 and a record $1B in January 2026 alone — here's who's writing the checks and where the capital is flowing.